review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | S A Harrison | |
J J Blonsky | |||
P2860 | cites work | Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress | Q27481013 |
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
High serum leptin is an independent risk factor for non-response patients with low viremia to antiviral treatment in chronic hepatitis C. | Q33788303 | ||
The evolving role of leptin and adiponectin in chronic liver diseases | Q36585280 | ||
Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C | Q37133483 | ||
IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins | Q40150504 | ||
Hepatitis C virus core protein induces hepatic steatosis in transgenic mice | Q42983905 | ||
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. | Q43042247 | ||
Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes | Q44675026 | ||
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States | Q45740183 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis C | Q154869 |
Hepatitis C virus | Q708693 | ||
liver disease | Q929737 | ||
metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
fatty liver disease | Q6058862 | ||
P304 | page(s) | 855-865 | |
P577 | publication date | 2008-02-29 | |
P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
P1476 | title | Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime | |
P478 | volume | 27 |
Q92583767 | A Novel Automatic Digital Algorithm that Accurately Quantifies Steatosis in NAFLD on Histopathological Whole-Slide Images |
Q43951080 | Associated factors with atherosclerosis in hepatitis C infection |
Q45064430 | Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum |
Q34812618 | Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease |
Q34246954 | Hepatic lipogranulomas in patients with chronic liver disease: Association with hepatitis C and fatty liver disease |
Q42239659 | IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative Study |
Q39040729 | Impact of hepatitis C virus therapy on metabolism and public health |
Q34023077 | Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection |
Q33855483 | Optimizing the dose and duration of therapy for chronic hepatitis C. |
Search more.